$12.800
+0.060 (+0.47%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Eloxx Pharmaceuticals Inc (ELOX) Moving Averages Convergence Divergence (MACD) indicator is -0.58, suggesting ELOX is Strong sell.
Eloxx Pharmaceuticals Inc (ELOX) 20-Day simple moving average is 13.02, while Eloxx Pharmaceuticals Inc (ELOX) share price is $—, making it Sell.
Eloxx Pharmaceuticals Inc (ELOX) 60-Day simple moving average is 15.37, while Eloxx Pharmaceuticals Inc (ELOX) share price is $—, making it Sell.
Technical Analysis for ELOX
AI Technical ELOXAs of 2026-11-02, the technical board for Eloxx Pharmaceuticals Inc (ELOX) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $12.44 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 38.61, MACD stands at -0.576 (Sell), Stochastic %K stands at 21.685, Stochastic %D stands at 27.495 and CCI stands at -153.87 (Buy).
ELOX trades below the 60-day SMA (15.37) and below the 200-day SMA (14.57). Immediate resistance sits at Classic R1 13.96, then R2 14.91. Support sits at Classic S1 12.08, then S2 11.15.
Eloxx Pharmaceuticals Inc (ELOX) Support & Resistance Level
Eloxx Pharmaceuticals Inc (ELOX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 38.610 |
| STOCHk_14_3_3 | 21.685 |
| STOCHd_14_3_3 | 27.495 |
| CCI_20 | -153.870 |
| AO_5_34 | -1.207 |
| MOM_10 | -0.360 |
| MACD_12_26_9 | -0.576 |
Eloxx Pharmaceuticals Inc (ELOX) Relative Strength Index (RSI_14) is 38.610, creating a Neutral signal.
Eloxx Pharmaceuticals Inc (ELOX) Stochastic %K is 21.685, creating a Neutral signal.
Eloxx Pharmaceuticals Inc (ELOX) Stochastic %D is 27.495, creating a Neutral signal.
Eloxx Pharmaceuticals Inc (ELOX) CCI_20 is -153.870, creating a Buy signal.
Eloxx Pharmaceuticals Inc (ELOX) Awesome Oscillator (AO) is -1.207, creating a Sell signal.
Eloxx Pharmaceuticals Inc (ELOX) Momentum (MOM) is -0.360, creating a Sell signal.
Eloxx Pharmaceuticals Inc (ELOX) Moving Average Convergence Divergence (MACD) is -0.576, creating a Sell signal.
Eloxx Pharmaceuticals Inc (ELOX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 12.748 | Sell |
| MA_10 | 13.002 | Sell |
| MA_20 | 13.024 | Sell |
| MA_60 | 15.374 | Sell |
| MA_200 | 14.567 | Sell |
| MA_250 | 14.567 | Sell |
Eloxx Pharmaceuticals Inc (ELOX) 5-Day simple moving average is 12.748, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Eloxx Pharmaceuticals Inc (ELOX) 10-Day simple moving average is 13.002, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Eloxx Pharmaceuticals Inc (ELOX) 20-Day simple moving average is 13.024, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Eloxx Pharmaceuticals Inc (ELOX) 60-Day simple moving average is 15.374, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Eloxx Pharmaceuticals Inc (ELOX) 200-Day simple moving average is 14.567, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Eloxx Pharmaceuticals Inc (ELOX) 250-Day simple moving average is 14.567, while Eloxx Pharmaceuticals Inc (ELOX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.